|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Net sales | |||
| Cost of goods sold | |||
| Gross profit | |||
| Operating expenses: | |||
| Selling, general and administrative expense | |||
| Research and development expenses | |||
| Total operating expenses | |||
| Loss from operations | |||
| Interest income (expense), net | |||
| Interest income, net | |||
| Financing costs | |||
| Change in fair value of warrant liabilities | |||
| Net Loss | |||
| Loss per common share, basic | |||
| Loss per common share, diluted | |||
| Weighted average common shares outstanding, basic | |||
| Weighted average common shares outstanding, diluted |
Loading...
